Cohen Fred E insider trades
Cohen Fred E has filed 25 Form 4s with the SEC that we hold, for CareDx, Inc. (CDNA) (Director), Intellia Therapeutics, Inc. (NTLA) (Director), Progyny, Inc. (PGNY) (Director) and UroGen Pharma Ltd. (URGN) (Director), among 5 companies in all. Across all of them we count 1 purchase worth $1.4M and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($1.4M) and 0 sales ($0). The largest single trade was a purchase of 150,000 shares of Intellia Therapeutics, Inc. worth $1.4M, dated 2026-01-05. The first filing on our record is dated 2021-10-26 and the latest 2026-06-16.
CareDx, Inc. (CDNA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Intellia Therapeutics, Inc. (NTLA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-01-05 | P, purchase reported on Form 4 | 150,000 | $1.4M | 2026-01-07 |
Progyny, Inc. (PGNY)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
UroGen Pharma Ltd. (URGN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Kyverna Therapeutics, Inc. (KYTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1339358) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms